Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

August 01, 2011; Volume 39,Issue 8

Short Communications

  • You have access
    Prolonged Toxic Effects After Cocaine Challenge in Butyrylcholinesterase/Plasma Carboxylesterase Double Knockout Mice: A Model for Butyrylcholinesterase-Deficient Humans
    Ellen G. Duysen and Oksana Lockridge
    Drug Metabolism and Disposition August 2011, 39 (8) 1321-1323; DOI: https://doi.org/10.1124/dmd.111.039917
  • You have access
    Effects of Ketamine on Human UDP-Glucuronosyltransferases In Vitro Predict Potential Drug-Drug Interactions Arising from Ketamine Inhibition of Codeine and Morphine Glucuronidation
    Verawan Uchaipichat, Pritsana Raungrut, Nuy Chau, Benjamas Janchawee, Allan M. Evans and John O. Miners
    Drug Metabolism and Disposition August 2011, 39 (8) 1324-1328; DOI: https://doi.org/10.1124/dmd.111.039727
  • You have access
    Characterization of Recombinant Human Carboxylesterases: Fluorescein Diacetate as a Probe Substrate for Human Carboxylesterase 2
    Jie Wang, Eric T. Williams, Joanne Bourgea, Y. Nancy Wong and Christopher J. Patten
    Drug Metabolism and Disposition August 2011, 39 (8) 1329-1333; DOI: https://doi.org/10.1124/dmd.111.039628
  • You have access
    Subcellular Location and Molecular Mobility of Human Cytosolic Sulfotransferase 1C1 in Living Human Embryonic Kidney 293 Cells
    Jonathan J. Sheng and George K. Acquaah-Mensah
    Drug Metabolism and Disposition August 2011, 39 (8) 1334-1337; DOI: https://doi.org/10.1124/dmd.111.039537

Articles

  • You have access
    Impact of Abcc2 [Multidrug Resistance-Associated Protein (Mrp) 2], Abcc3 (Mrp3), and Abcg2 (Breast Cancer Resistance Protein) on the Oral Pharmacokinetics of Methotrexate and Its Main Metabolite 7-Hydroxymethotrexate
    Maria L. H. Vlaming, Anita van Esch, Evita van de Steeg, Zeliha Pala, Els Wagenaar, Olaf van Tellingen and Alfred H. Schinkel
    Drug Metabolism and Disposition August 2011, 39 (8) 1338-1344; DOI: https://doi.org/10.1124/dmd.111.038794
  • You have access
    Human Paraoxonase 1 Is the Enzyme Responsible for Pilocarpine Hydrolysis
    Tomomi Hioki, Tatsuki Fukami, Miki Nakajima and Tsuyoshi Yokoi
    Drug Metabolism and Disposition August 2011, 39 (8) 1345-1352; DOI: https://doi.org/10.1124/dmd.111.038141
  • You have access
    In Vitro Age-Dependent Enzymatic Metabolism of Chlorpyrifos and Chlorpyrifos-Oxon in Human Hepatic Microsomes and Chlorpyrifos-Oxon in Plasma
    Jordan Ned Smith, Charles Timchalk, Michael J. Bartels and Torka S. Poet
    Drug Metabolism and Disposition August 2011, 39 (8) 1353-1362; DOI: https://doi.org/10.1124/dmd.111.038745
  • You have access
    Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats
    Judith Naud, Josée Michaud, Stéphanie Beauchemin, Marie-Josée Hébert, Michel Roger, Stéphane Lefrancois, Francois A. Leblond and Vincent Pichette
    Drug Metabolism and Disposition August 2011, 39 (8) 1363-1369; DOI: https://doi.org/10.1124/dmd.111.039115
  • You have access
    An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes
    Andrew Parkinson, Faraz Kazmi, David B. Buckley, Phyllis Yerino, Brandy L. Paris, Jeff Holsapple, Paul Toren, Steve M. Otradovec and Brian W. Ogilvie
    Drug Metabolism and Disposition August 2011, 39 (8) 1370-1387; DOI: https://doi.org/10.1124/dmd.111.038596
  • You have access
    Development of a Highly Sensitive Cytotoxicity Assay System for CYP3A4-Mediated Metabolic Activation
    Hiroko Hosomi, Tatsuki Fukami, Atsushi Iwamura, Miki Nakajima and Tsuyoshi Yokoi
    Drug Metabolism and Disposition August 2011, 39 (8) 1388-1395; DOI: https://doi.org/10.1124/dmd.110.037077
  • You have access
    Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist
    Peter J. Bungay, Sarah Tweedy, David C. Howe, Karl R. Gibson, Hannah M. Jones and Natalie M. Mount
    Drug Metabolism and Disposition August 2011, 39 (8) 1396-1405; DOI: https://doi.org/10.1124/dmd.110.037234
  • You have access
    Microsomal Quercetin Glucuronidation in Rat Small Intestine Depends on Age and Segment
    Bradley W. Bolling, Michael H. Court, Jeffrey B. Blumberg and C.-Y. Oliver Chen
    Drug Metabolism and Disposition August 2011, 39 (8) 1406-1414; DOI: https://doi.org/10.1124/dmd.111.038406
  • You have access
    Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture
    Leslie J. Dickmann, Sonal K. Patel, Dan A. Rock, Larry C. Wienkers and J. Greg Slatter
    Drug Metabolism and Disposition August 2011, 39 (8) 1415-1422; DOI: https://doi.org/10.1124/dmd.111.038679
  • You have access
    The Imidazoacridinone Antitumor Drug, C-1311, Is Metabolized by Flavin Monooxygenases but Not by Cytochrome P450s
    Agnieszka Potega, Emilia Dabrowska, Magdalena Niemira, Agata Kot-Wasik, Sebastien Ronseaux, Colin J. Henderson, C. Roland Wolf and Zofia Mazerska
    Drug Metabolism and Disposition August 2011, 39 (8) 1423-1432; DOI: https://doi.org/10.1124/dmd.111.038984
  • You have access
    Identification of Cytochrome P450 Oxidoreductase Gene Variants That Are Significantly Associated with the Interindividual Variations in Warfarin Maintenance Dose
    Xiuling Zhang, Lei Li, Xinxin Ding and Laurence S. Kaminsky
    Drug Metabolism and Disposition August 2011, 39 (8) 1433-1439; DOI: https://doi.org/10.1124/dmd.111.038836
  • You have access
    Acute Doxorubicin Toxicity Differentially Alters Cytochrome P450 Expression and Arachidonic Acid Metabolism in Rat Kidney and Liver
    Beshay N. M. Zordoky, Anwar Anwar-Mohamed, Mona E. Aboutabl and Ayman O. S. El-Kadi
    Drug Metabolism and Disposition August 2011, 39 (8) 1440-1450; DOI: https://doi.org/10.1124/dmd.111.039123
  • You have access
    Farnesoid X Receptor Activation by Chenodeoxycholic Acid Induces Detoxifying Enzymes through AMP-Activated Protein Kinase and Extracellular Signal-Regulated Kinase 1/2-Mediated Phosphorylation of CCAAT/Enhancer Binding Protein β
    Kyoung Noh, Young Mi Kim, Young Woo Kim and Sang Geon Kim
    Drug Metabolism and Disposition August 2011, 39 (8) 1451-1459; DOI: https://doi.org/10.1124/dmd.111.038414
  • You have access
    A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry
    Richard A. Graham, Bert L. Lum, Glenn Morrison, Ilsung Chang, Karin Jorga, Brian Dean, Young G. Shin, Qin Yue, Teresa Mulder, Vikram Malhi, Minli Xie, Jennifer A. Low and Cornelis E. C. A. Hop
    Drug Metabolism and Disposition August 2011, 39 (8) 1460-1467; DOI: https://doi.org/10.1124/dmd.111.039339
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 39 (8)
Drug Metabolism and Disposition
Vol. 39, Issue 8
1 Aug 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics